
What is the stock price of Alkermes plc?
Alkermes plc's stock symbol is ALKS and currently trades under NASDAQ. It’s current price per share is approximately $ 30.69. When is Alkermes plc's next earnings date?
What price target do analysts set for AlkS?
What price target have analysts set for ALKS? 10 Wall Street analysts have issued twelve-month price objectives for Alkermes' stock. Their forecasts range from $15.00 to $28.00. On average, they anticipate Alkermes' stock price to reach $20.50 in the next year.
Where can I buy AlkS shares?
Shares of ALKS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
When does AlkS earnings call for 2019?
ALKS earnings call for the period ending December 31, 2019. ALKS earnings call for the period ending September 30, 2019.
Should I buy or sell Alkermes stock right now?
9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alkermes in the last year. There are currently 1 sell ra...
What is Alkermes' stock price forecast for 2022?
9 analysts have issued twelve-month price targets for Alkermes' shares. Their forecasts range from $25.00 to $36.00. On average, they expect Alkerm...
How has Alkermes' stock performed in 2022?
Alkermes' stock was trading at $23.26 at the start of the year. Since then, ALKS stock has increased by 18.1% and is now trading at $27.46. View t...
When is Alkermes' next earnings date?
Alkermes is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022. View our earnings forecast for Alkermes .
How were Alkermes' earnings last quarter?
Alkermes plc (NASDAQ:ALKS) posted its earnings results on Wednesday, April, 27th. The company reported $0.01 earnings per share for the quarter, be...
What guidance has Alkermes issued on next quarter's earnings?
Alkermes updated its FY22 earnings guidance on Wednesday, April, 27th. The company provided earnings per share guidance of $(0.18)-0.00 for the per...
Who are Alkermes' key executives?
Alkermes' management team includes the following people: Mr. Richard F. Pops , Chairman & CEO (Age 60, Pay $2.28M) Mr. Iain Michael Brown , Sr....
What is Richard F. Pops' approval rating as Alkermes' CEO?
119 employees have rated Alkermes CEO Richard F. Pops on Glassdoor.com . Richard F. Pops has an approval rating of 84% among Alkermes' employees.
Who are some of Alkermes' key competitors?
Some companies that are related to Alkermes include Amgen (AMGN) , Gilead Sciences (GILD) , Vertex Pharmaceuticals (VRTX) , Regeneron Pharmaceu...
How much does Alkermes make?
Is Alkermes a hold?
Alkermes has a market capitalization of $3.93 billion and generates $1.04 billion in revenue each year. The company earns $-110,860,000.00 in net income (profit) each year or ($0.14) on an earnings per share basis.
Nasdaq Global Select
Wall Street analysts have given Alkermes a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Alkermes wasn't one of them.
Environmental, Social, and Governance Rating
A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
Transparency is our policy. Learn how it impacts everything we do
A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.
How we make money
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
How we use your personal data
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.
How we approach editorial content
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
